Reports >
Life Sciences
>
Ngs Based Rna Sequencing Market Report
Ngs Based Rna Sequencing Market Report
First published: 15 October 2024 | Last updated: 08 July 2026 | Report Code: ngs-based-rna-sequencing
Ngs Based Rna Sequencing Market — USD 2.5 billion in 2023, Growing to USD 8.13B by 2033 at 12% CAGR
This report provides a comprehensive analysis of the NGS-based RNA sequencing market, focusing on market size, growth trends, regional insights, and industry dynamics from 2023 to 2033.
Key Takeaways
- Global market expands from $2.50 Billion in 2023 to $8.13 Billion in 2033 at a 12% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- North America is the largest region, increasing from $0.84 Billion in 2023 to $2.74 Billion in 2033.
- Europe grows from $0.74 Billion to $2.4 Billion between 2023 and 2033, supported by research investment.
- Asia Pacific advances from $0.5 Billion to $1.64 Billion as genomic research activity rises.
- Top companies include Illumina, Inc, Thermo Fisher Scientific Inc., Qiagen N.V., and Roche Holding AG.
Ngs Based Rna Sequencing Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The Ngs Based Rna Sequencing Market Report outlines a significant expansion from $2.50 Billion in 2023 to $8.13 Billion by 2033, guided by a 12% CAGR over the 2023 to 2033 forecast. Growth is propelled by technological improvements in next-generation sequencing, lower sequencing costs, and growing uptake across clinical research, academic institutions, and biotechnology firms. Key product and service categories include consumables, instrumentation, and software workflows, while applications span clinical research, genome annotation, and agricultural studies. Regional performance is varied: North America is the largest market, with Europe and Asia Pacific also showing substantial increases. Major suppliers such as Illumina, Inc, Thermo Fisher Scientific Inc., Qiagen N.V., and Roche Holding AG are active in product innovation and partnerships. The report highlights trends like increased single-cell approaches and expanded clinical adoption, alongside operational challenges in data management and analysis. These dynamics shape strategic planning for stakeholders across the value chain.
Key Growth Drivers
- Technological advances in high-throughput NGS platforms improving sensitivity and throughput.
- Declining per-sample sequencing costs enabling broader adoption across research and clinical settings.
- Rising use of RNA sequencing in clinical research, academic studies, and biotechnology development.
- Increased public and private funding for genomics research driving demand for NGS solutions.
- Product innovation and collaborations among leading firms expanding application-specific capabilities.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $2.50 Billion |
| CAGR (2023-2033) | 12% |
| 2033 Market Size | $8.13 Billion |
| Top Companies | Illumina, Inc, Thermo Fisher Scientific Inc., Qiagen N.V., Roche Holding AG |
| Published Date | 15 October 2024 |
| Last Modified Date | 08 July 2026 |
Ngs Based Rna Sequencing Market Overview
Customize Ngs Based Rna Sequencing Market Report market research report
- ✔ Get in-depth analysis of Ngs Based Rna Sequencing market size, growth, and forecasts.
- ✔ Understand Ngs Based Rna Sequencing's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Ngs Based Rna Sequencing
What is the Market Size & CAGR of Ngs Based Rna Sequencing Market Report market in 2023?
Ngs Based Rna Sequencing Industry Analysis
Ngs Based Rna Sequencing Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Ngs Based Rna Sequencing Market Report Market Analysis Report by Region
Europe Ngs Based Rna Sequencing Market Report:
Europe grows from $0.74 Billion in 2023 to $2.4 Billion in 2033. Growth reflects growing public and private investment in genomics research, collaborative projects between academia and industry, and rising clinical research applications.Asia Pacific Ngs Based Rna Sequencing Market Report:
Asia Pacific grows from $0.5 Billion in 2023 to $1.64 Billion in 2033. Expansion is supported by increasing research capacity, rising biotechnology activity, and greater access to sequencing technologies across research institutions.North America Ngs Based Rna Sequencing Market Report:
North America is largest regional market, rising from $0.84 Billion in 2023 to $2.74 Billion in 2033. Regional strength is driven by established research infrastructure, significant clinical and academic sequencing activity, and strong presence of key industry players supporting product availability and adoption.South America Ngs Based Rna Sequencing Market Report:
Latin America grows from $0.22 Billion in 2023 to $0.71 Billion in 2033. Regional uptake is influenced by expanding research programs, growing interest in genomics applications, and improved access to sequencing consumables and instruments.Middle East & Africa Ngs Based Rna Sequencing Market Report:
Middle East and Africa grows from $0.2 Billion in 2023 to $0.64 Billion in 2033. Growth drivers include nascent research investments, partnerships with global suppliers, and gradual adoption of sequencing platforms in clinical and academic settings.Tell us your focus area and get a customized research report.
Research Methodology
Ngs Based Rna Sequencing Market Analysis By Technology
The NGS-based RNA sequencing market is primarily divided into single-end sequencing and paired-end sequencing. Single-end sequencing dominates the market with a significant share of 82.09% in 2023, valued at $2.05 billion and reaching $6.68 billion by 2033. Paired-end sequencing holds a smaller share at 17.91%, with estimates of growing from $0.45 billion in 2023 to $1.46 billion in 2033.
Ngs Based Rna Sequencing Market Analysis By Application
Academic and clinical research are the two primary applications of NGS-based RNA sequencing. Academic research is expected to grow significantly, with a size of $1.70 billion in 2023 and projected to reach $5.54 billion by 2033. Clinical research mirrors this trend with a similar growth trajectory, indicating the essential role of RNA sequencing in healthcare advancements.
Ngs Based Rna Sequencing Market Analysis By End User
The primary end-users of the NGS-based RNA sequencing market include academic research institutions, biotechnology companies, and hospitals/clinics. Academic research leads the market with a share of 68.13% in 2023, while biotechnology companies and healthcare providers account for 20.62% and 11.25% respectively, highlighting the diverse applications of RNA systems across various sectors.
Ngs Based Rna Sequencing Market Analysis By Instrumentation
Instrumentation plays a crucial role in NGS-based RNA sequencing, categorized into sequencers, workstations, kits, and reagents. Sequencers hold a dominant position with a market size of $2.05 billion in 2023, expected to grow to $6.68 billion by 2033. Reagents and kits are also key components, with significant shares of 82.09% and 17.91% respectively, reflecting their importance in the operational workflow.
Ngs Based Rna Sequencing Market Analysis By Consumables
Consumables such as reagents, kits, and workstations are integral to the NGS-based RNA sequencing market. In 2023, reagents are projected at $2.05 billion, constituting the bulk of the market at 82.09%, with expected growth to $6.68 billion by 2033. The substantial demand for consumables underlines their critical role in ensuring efficient sequencing operations as the market expands.
Ngs Based Rna Sequencing Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Ngs Based Rna Sequencing Industry
Illumina, Inc:
A leader in the genomic sequencing space, Illumina offers innovative solutions and technology for NGS-based RNA sequencing, facilitating advancements in genomic research.Thermo Fisher Scientific Inc.:
Thermo Fisher provides comprehensive sequencing solutions and reagents, contributing significantly to the growth and accessibility of NGS technologies.Qiagen N.V.:
Qiagen specializes in sample preparation technology and bioinformatics, playing a vital role in advancing RNA sequencing capabilities for research and clinical applications.Roche Holding AG:
Roche is a global leader in healthcare, providing cutting-edge sequencing platforms and solutions that enhance RNA sequencing applications across various diseases.We're grateful to work with incredible clients.
FAQs
What is the market size of the Ngs Based Rna Sequencing Market Report in 2023?
The market size for 2023 is $2.50 Billion as reported.
How big will the Ngs Based Rna Sequencing Market Report market be in 2033?
The market is projected to reach $8.13 Billion by 2033 according to the provided forecast.
What is CAGR for the forecast period?
The compound annual growth rate (CAGR) for 2023 to 2033 is 12% as stated in the report data.
Is there a single fastest Growing region in the Ngs Based Rna Sequencing Market Report market?
No single fastest-growing region is stated for the Ngs Based Rna Sequencing Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies are listed as top players?
Top companies identified include Illumina, Inc, Thermo Fisher Scientific Inc., Qiagen N.V., and Roche Holding AG.
What are common applications driving demand?
Applications include clinical research, genome annotation, and agriculture, which increase demand for sequencing and associated workflows.
How are consumables categorized in the report?
Consumables are segmented into reagents and kits, both highlighted as primary subsegments in the market structure.
What is the forecast period for this market report?
The forecast period covered is 2023 to 2033.
Who participates in the by End User segment?
End-users listed include academic research, biotechnology companies, and hospitals and clinics as primary subsegments.
Which sequencing technologies are covered?
Technology subsegments include single-end sequencing and paired-end sequencing as cited in the segmentation.